ADC Therapeutics (ADCT) Tax Provisions (2020 - 2025)
ADC Therapeutics (ADCT) posted Tax Provisions of $1.3 million for Q2 2025, up 660.0% sequentially from $165000.0 in Q1 2025, and up 435.9% YoY from $234000.0 in Q2 2024.
ADC Therapeutics (ADCT) Tax Provisions (2020 - 2025) Analysis & Trends
ADC Therapeutics has reported Tax Provisions for 6 years, with the latest figure at $1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 165,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 234,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -4.50 Mn |
| Mar 31, 2023 | -262,000.00 |
| Sep 30, 2022 | -711,000.00 |
| Jun 30, 2022 | -947,000.00 |
| Mar 31, 2022 | -1.17 Mn |
| Sep 30, 2021 | 145,000.00 |
| Jun 30, 2021 | 240,000.00 |
| Mar 31, 2021 | 107,000.00 |
| Sep 30, 2020 | -3,000.00 |
| Jun 30, 2020 | 104,000.00 |
| Mar 31, 2020 | 100,000.00 |